Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Novartis
Novartis
Kivu Bioscience Inc.
Hoffmann-La Roche
Endeavor Biomedicines, Inc.
City of Hope Medical Center
Aveni Foundation
M.D. Anderson Cancer Center
University of California, Irvine
M.D. Anderson Cancer Center
ViroMissile, Inc.
AstraZeneca
Washington University School of Medicine
Essen Biotech